(Q45855508)

17 December 2017

title

Readministration of helper-dependent adenovirus to mouse lung (English)

1 reference

17 December 2017

1 reference

D R Koehler

1

1 reference

17 December 2017

B Martin

2

1 reference

17 December 2017

M Corey

3

1 reference

17 December 2017

D Palmer

4

1 reference

17 December 2017

P Ng

5

1 reference

17 December 2017

A K Tanswell

6

1 reference

17 December 2017

J Hu

7

1 reference

17 December 2017

publication date

1 May 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

773-780

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302712

exact match

0 references

cites work

An overview of the pathogenesis of cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Challenges and strategies for cystic fibrosis lung gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Role of viral vectors and virion shells in cellular gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Immunological memory and protective immunity: understanding their relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Optimization of the helper-dependent adenovirus system for production and potency in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Improved system for helper-dependent adenoviral vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

Multiple advantages of alpha-fetoprotein as a marker for in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

The molecular basis for disease variability in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302712

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302712

1 reference

17 December 2017

Dimensions Publication ID

1041114159

0 references

Fatcat ID

release_5vbpw2oax5b5dithei3rsfolnq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5vbpw2oax5b5dithei3rsfolnq

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017